(FY)Jul 31, 2023 | |
---|---|
Operating Cash Flow (Indirect Method) | |
Cash flow from continuing operating activities | -11.1K |
Net income from continuing operations | ---11.1K |
Change In working capital | --0 |
-Change in prepaid assets | --0 |
-Change in payables and accrued expense | --0 |
Cash from discontinued investing activities | |
Operating cash flow | ---11.1K |
Investing cash flow | |
Cash flow from continuing investing activities | 0 |
Net PPE purchase and sale | --0 |
Cash from discontinued investing activities | |
Investing cash flow | --0 |
Financing cash flow | |
Cash flow from continuing financing activities | 11.1K |
Net issuance payments of debt | --11.1K |
Net common stock issuance | --0 |
Cash from discontinued financing activities | |
Financing cash flow | --11.1K |
Net cash flow | |
Beginning cash position | --76 |
End cash Position | --76 |
Free cash flow | ---11.1K |
Currency Unit | USD |
Audit Opinions | Unaudited |
No Data
No Data